BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2558669)

  • 1. Binding of radiation leukemia viruses to a thymic lymphoma involves some class I molecules on the T cell as well as the T cell receptor complex.
    O'Neill HC
    J Mol Cell Immunol; 1989; 4(4):213-23. PubMed ID: 2558669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique role for the T cell receptor in retrovirus binding by the C6VL thymoma.
    O'Neill HC
    Int Immunol; 1990; 2(4):377-80. PubMed ID: 2177645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of binding specificity between T cell lymphomas and murine leukemia viruses.
    O'Neill HC; Weissman IL
    J Immunol Methods; 1989 Aug; 122(1):79-90. PubMed ID: 2547874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation leukemia virus-induced T-cell lymphomas with common T-cell receptor variable region structure and similar binding specificity for retrovirus.
    O'Neill HC
    Leukemia; 1991 Nov; 5(11):921-7. PubMed ID: 1961032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subset of T cell receptors associated with L3T4 molecules mediates C6VL leukemia cell binding of its cognate retrovirus.
    O'Neill HC; McGrath MS; Allison JP; Weissman IL
    Cell; 1987 Apr; 49(1):143-51. PubMed ID: 2435413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2 and antibody to the T cell receptor regulate proliferation of a radiation leukemia virus-transformed T cell lymphoma.
    O'Neill HC
    Leukemia; 1988 Feb; 2(2):108-14. PubMed ID: 2830440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of potential lymphoma-inducing cells in mice sensitive or resistant to lymphomagenesis by radiation leukemia virus variants.
    Gokhman I; Peled A; Haran-Ghera N
    Cancer Res; 1990 May; 50(9):2554-61. PubMed ID: 2158393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a T cell receptor-like molecule on normal and malignant murine T cells detected by rat monoclonal antibodies to nonclonotypic determinants.
    Chan PY; Takei F
    J Immunol; 1986 Feb; 136(4):1346-53. PubMed ID: 2418112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8 inhibits signal transduction through the T cell receptor in CD4-CD8- thymocytes from T cell receptor transgenic mice reconstituted with a transgenic CD8 alpha molecule.
    van Oers NS; Teh SJ; Garvin AM; Forbush KA; Perlmutter RM; Teh HS
    J Immunol; 1993 Jul; 151(2):777-90. PubMed ID: 8335907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
    Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP
    J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules.
    Kisielow P; Teh HS; Blüthmann H; von Boehmer H
    Nature; 1988 Oct; 335(6192):730-3. PubMed ID: 3262831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):24-7. PubMed ID: 6202782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymocyte antigens do not induce tolerance in the CD4+ T cell compartment.
    Jhaver KG; Chandler P; Simpson E; Mellor AL
    J Immunol; 1999 Nov; 163(9):4851-8. PubMed ID: 10528186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal analysis of H-2Kb + TNP recognition by T cells with the use of H-2Kbm mutants and H-2Kb-specific monoclonal antibodies.
    Davignon JL; Guimezanes A; Schmitt-Verhulst AM
    J Immunol; 1983 Sep; 131(3):1073-9. PubMed ID: 6193173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCR vaccines against T cell lymphoma: QS-21 and IL-12 adjuvants induce a protective CD8+ T cell response.
    Wong CP; Okada CY; Levy R
    J Immunol; 1999 Feb; 162(4):2251-8. PubMed ID: 9973501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.
    McDougal JS; Nicholson JK; Cross GD; Cort SP; Kennedy MS; Mawle AC
    J Immunol; 1986 Nov; 137(9):2937-44. PubMed ID: 2428879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restricted blocking of cytotoxic T-cell function by anti-H-2K/D antibodies.
    O'Neill HC
    Immunology; 1988 Feb; 63(2):241-6. PubMed ID: 3258275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.